World News

ESMO Launches Living Guidelines to Enhance the Usability of its Clinical...

Ogkologos - 10 Μαΐου, 2023

Favourable Benefit-Risk Profile of Trastuzumab Deruxtecan in Patients with HER2-positive MBC...

Ogkologos - 10 Μαΐου, 2023

Elliot Colburn MP: Why Cancer Research UK’s Manifesto for Cancer Research...

Ogkologos - 9 Μαΐου, 2023

Cancer in My Community: Accessing Care Through the Public Health System...

Ogkologos - 9 Μαΐου, 2023

How MRI add-ons could accelerate the development of new treatments

Ogkologos - 9 Μαΐου, 2023

A Combination of Trifluridine-Tipiracil Plus Bevacizumab Results in Longer Overall Survival...

Ogkologos - 9 Μαΐου, 2023

Temporary Interruption of Adjuvant Endocrine Treatment to Attempt Pregnancy Does Not...

Ogkologos - 8 Μαΐου, 2023

Rare Melanoma Very Likely to Respond to Treatment with Pembrolizumab

Ogkologos - 5 Μαΐου, 2023

People who’ve had radiotherapy shape our new policy calls

Ogkologos - 4 Μαΐου, 2023

What to Know About Navigating Cancer Care With a Disability: An...

Ogkologos - 4 Μαΐου, 2023

1...132133134...432 Σελίδα 133 από 432

MOST POPULAR

Nivolumab: Μία σημαντική θεραπευτική επιλογή

3 Νοεμβρίου, 2019

Έγκριση νέας επικουρικής θεραπείας για τον θετικά πρώιμο καρκίνο του μαστού

24 Ιουνίου, 2019

Newly Developed International Childhood Cancer Core Outcome Set Represents Physical, Psychosocial,...

11 Ιουλίου, 2023

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

4 Φεβρουαρίου, 2026

Φόρτωση περισσοτέρων

ESMO Launches Living Guidelines to Enhance the Usability of its Clinical...

Favourable Benefit-Risk Profile of Trastuzumab Deruxtecan in Patients with HER2-positive MBC...

Elliot Colburn MP: Why Cancer Research UK’s Manifesto for Cancer Research...

Cancer in My Community: Accessing Care Through the Public Health System...

How MRI add-ons could accelerate the development of new treatments

A Combination of Trifluridine-Tipiracil Plus Bevacizumab Results in Longer Overall Survival...

Temporary Interruption of Adjuvant Endocrine Treatment to Attempt Pregnancy Does Not...

Rare Melanoma Very Likely to Respond to Treatment with Pembrolizumab

People who’ve had radiotherapy shape our new policy calls

What to Know About Navigating Cancer Care With a Disability: An...

MOST POPULAR

Nivolumab: Μία σημαντική θεραπευτική επιλογή

Έγκριση νέας επικουρικής θεραπείας για τον θετικά πρώιμο καρκίνο του μαστού

Newly Developed International Childhood Cancer Core Outcome Set Represents Physical, Psychosocial,...

ESMO Launches Its Roadmap 2030 to Support Oncology Professionals and Foster...

HOT NEWS

Could Cholesterol-Lowering Drugs Improve Cancer Immunotherapy?

Liquid Biopsy May Predict Risk of Breast Cancer Returning Years Later

Mutational Patterns Drive Metastatic Aggressiveness of Appendiceal Adenocarcinomas

FDA Grants Accelerated Approval to Asciminib for Newly Diagnosed Chronic Myeloid...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ